بررسي مديريت بيهوشي حين عمل و پيامدهاي بعد از عمل در بيماران با عمل جراحي پيوند قلب در مركز آموزشي تحقيقاتي و درماني قلب و عروق شهيدرجايي در سالهاي 1398-1393
مجله انجمن آنستزیولوژی و مراقبتهای ویژه ایران,
,
23 أيلول 2020
,
صفحه 31-43
چکیده
پيوند قلب عمل طلايي جراحي است كه طي آن قلب دچار نارسايي و بيماري با قلب اهدايي كه از سلامت بيشتري برخوردار است جايگزين مي شود. انتخاب پيوند قلب زماني به عنوان گزينه درماني صورت مي گيرد كه مصرف داروها و يا ساير جراحي ها و اقدامات انجام شده باشد و عارضه قلبي كماكان ادامه يافته و بهبودي حاصل نشده باشد. عمل جراحي پيوند قلب نخستين بار در سال 1967 ميلادي توسط پروفسور بارنارد در كيپ تاون آفريقاي جنوبي انجام شد و با فراز و نشيب هايي پشت سر گذاشته در حال حاضر سالانه نزديك 4000 عمل پيوند قلب در دنيا انجام مي شود كه سهم جمهوري اسلامي ايران كمتر از 200 مورد در سال است.- پيوند قلب، پروفسور بارنارد، خون ريزي، نارسايي قلب، انتخاب روش بيهوشي
ارجاع به مقاله
مراجع
-Aliabadi A, Cochrane AB, Zuckermann AO. Current strategies and future trends in immunosuppression after heart transplantation. Curr Opin Organ Transplant 2012; 17(5): 540-5.
-Aliabadi A, Cochrane AB, Zuckermann AO. Current strategies and future trends in immunosuppressionafter heart transplantation. Curr Opin Organ Transplant 2012; 17: 540-5.
-Ashary N, Kaye AD, Hegazi AR. EA MF. Anesthetic considerations in the patient with a heart transplant. Heart Dis 2002; 4: 191-8.
-Bennett GM, Stanley TH. Cardiovascular effects of fentanyl during enflurane anesthesia in man. Anesth Analg 1979; 58: 179-82.
-Bovill JG, Sebel PS, Stanley TH. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology 1984; 61: 731-55.
-Braunwald E. Heart failure: pathophysiology and treatment. Am Heart J 1981; 102: 486-90.
Colvin MP, Savege TM, Newland PE, et al. Cardiorespiratory changes following induction of anaesthesia with etomidate in patients with cardiac disease. Br J Anaesth 1979; 51: 551-6.
-Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg 2006; 81: 397-404.
-Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg 2007; 83: 1569-76.
-Fonger JD, Borkon AM, Baumgartner WA, Achuff SC, Augustine S, Reitz BA. Acute right ventricular failure following heart transplantation: Improvement with prostaglandin E1 and right ventricular assist. J Heart Transplant 1986;5:317-21.
-Fragen RJ, Shanks CA, Molteni A, Avram MJ. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 1984; 61: 652-6.
-Griepp RB, Ergin MA. The history of experimental heart transplantation. Heart Transplant 1984; 3: 145.
-Harish R, Kent H, et al. Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation. Current Clinical Pharmacology2015;Vol 10,No(1):2-21.
Hensley FA Jr, Martin DE, Larach DR, Romanoff ME. Anesthetic management for cardiac transplantation in North America--1986 survey. J Cardiothorac Anesth 1987;1:429-37.
;97:2079-90.
-Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report-2000. J Heart Lung Transplant 2000;19:909-31.
-Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation
-Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg 2010; 110: 21-9.
-Kfoury AG, Hammond ME. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant 2010; 29: 389-94.
-Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30: 252-69.
-Ledingham IM, Finlay WEI, Watt I, et al. Etomidate and adrenocortical function. Lancet 1983; 321: 1434.
-Lewen MK, Bryg RJ, Miller LW, Williams GA, Labovitz AJ. Tricuspid regurgitation by Doppler echocardiography after orthotopic cardiac transplantation. Am J Cardiol 1987;59:1371-4
-Lindenfeld J, Miller GG, Shakar SF, et al. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation 2004; 110: 3734-40.
-Lindenfeld J, Miller GG, Shakar SF, et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation 2004; 110: 3858-65.
-Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
-Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-65.
-Mann FC, Priestley JT, Markowitz J, Yater WM. Transplantation of the intact mammalian heart. Arch Surg 1933;26:219-24.
-Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356: 2301-11.
-Martin K, Wiesner G, Breuer T, Lange R, Tassani P. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107: 1783-90.
-Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001; 71: 1428-32.
-Miniati DN, Hunt SA, Robbins RC. Treatment options for patients with severe myocardial failure: A review of the latest technology. ACC Curr Jr Rev 1999;8:44-8.
-Nwakarma LU, Weiss ES, Patel ND, Baumgartner WA, Russell SD, Conte JV. Reversible pulmonary hypertension has comparable survival: An analysis of 10,331 heart transplant patients in recent era. Circulation 2007;116:664.
-Ramakrishna H, Jaroszewski DE, Arabia FA. Adult cardiac transplantation: a review of perioperative management (part-II). Ann Card Anaesth 2009; 12: 155-65.
-Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg 2011; 142: 662-7.
-Sokoll MD, Hoyt JL, Gergis SD. Studies in muscle rigidity, nitrous oxide, and narcotic analgesic agents. Anesth Analg 1972; 51: 16-20.
-Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh Official Adult Heart Transplant Report--2010. J Heart Lung Transplant 2010; 29: 1089-103.
-Sunzel M, Paalzow L, Berggren L, Eriksson I. Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam. Br J Clin Pharmacol 1988; 25: 561-9
-Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010; 90: 1270-7.
- چکیده مشاهده شده: 190 بار
- PDF دانلود شده: 87 بار